These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 203832

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. [Treatment of hyperlipidaemia. A comparison of the efficacy of clofibrate and beta-pyridylcarbinol (author's transl)].
    Wolfram G, Keller C, Kilani S, Zöllner N.
    Dtsch Med Wochenschr; 1976 Jan 16; 101(3):76-81. PubMed ID: 1245160
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. [Constellation of lipoproteins in patients with hyperlipoproteinemia and in rabbits fed a cholesterol diet with reference to vascular permeability].
    Herrmann W, Reuter W.
    Z Gesamte Inn Med; 1977 Dec 15; 32(24):682-2. PubMed ID: 204118
    [Abstract] [Full Text] [Related]

  • 25. [Use of miskleron in ischemic heart disease with differing types of hyperlipoproteinemias].
    Krivoruchenko IV, Nikul'cheva NG.
    Kardiologiia; 1976 Jul 15; 16(7):71-5. PubMed ID: 185448
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. A comparative trial of clofibrate and nicotinyl alcohol tartrate in hyperlipoproteinemic patients.
    Dujovne CA, Azarnoff DL, Pentikainen P, Manion CV, Hurwitz A.
    Am J Med Sci; 1979 Jul 15; 277(3):255-61. PubMed ID: 222145
    [Abstract] [Full Text] [Related]

  • 29. [On the effect of etofylline clofibrate on serum lipids and lipoproteins in patients with hyperlipoproteinemia of various degrees (author's transl)].
    Schneider J, Mühlfellner G, Mühlfellner O, Hausmann L, Schubotz R.
    Arzneimittelforschung; 1980 Jul 15; 30(11b):2059-62. PubMed ID: 7194060
    [Abstract] [Full Text] [Related]

  • 30. [Comparative studies on the cholesterol and triglyceride-lowering effect of alpha-methylthyroxine (Skleronorm) and clofibrate (Regelan) in hyperlipoproteinemias of type IIa/b and IV].
    Jantke J, Schwartzkopff W, Zschiedrich M.
    Verh Dtsch Ges Inn Med; 1980 Jul 15; 83():392-5. PubMed ID: 206057
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [Treatment of primary hyperlipoproteinemias. Comparison of N 041 with clofibrate].
    Gaertner U, Johannes KJ.
    MMW Munch Med Wochenschr; 1976 Sep 03; 118(36):1127-30. PubMed ID: 184377
    [Abstract] [Full Text] [Related]

  • 33. Effect of calcium p-chlorphenoxyisobutyrate and calcium carbonate on plasma lipids and lipoproteins of patients with hyperlipoproteinaemia.
    Koskinen P, Inkovaara J, Ala-Kaila K, Salo M, Nikkari T.
    Ann Clin Res; 1977 Dec 03; 9(6):335-41. PubMed ID: 356720
    [Abstract] [Full Text] [Related]

  • 34. [Therapy of primary hyperlipoproteinemia types IIa, IIb and IV using beta pyridylcarbinol Study on three phases under ambulatory conditions].
    Klemens UH, von Löwis P.
    Dtsch Med Wochenschr; 1973 Jun 15; 98(24):1197-202. PubMed ID: 4350685
    [No Abstract] [Full Text] [Related]

  • 35. Xanthomatosis and hyperlipoproteinemia; a review.
    Polano MK.
    Dermatologica; 1974 Jun 15; 149(1):1-9. PubMed ID: 4372111
    [No Abstract] [Full Text] [Related]

  • 36. Bile acid kinetics and steroid balance during nicotinic acid therapy in patients with hyperlipoproteinemia types II and IV.
    Einarsson K, Hellström K, Leijd B.
    J Lab Clin Med; 1977 Oct 15; 90(4):613-22. PubMed ID: 198500
    [No Abstract] [Full Text] [Related]

  • 37. [Clinical study with a new antihyperlipemic combination].
    Pistautz H.
    Arzneimittelforschung; 1977 Oct 15; 27(1):152-6. PubMed ID: 576816
    [Abstract] [Full Text] [Related]

  • 38. [Effect of etofylline clofibrate on the composition of lipoproteins in hyperlipidaemia type IIb and IV (author's transl)].
    Ditschuneit HH, Hutt V, Klör HU, Ditschuneit H.
    Arzneimittelforschung; 1980 Oct 15; 30(11b):2063-7. PubMed ID: 7194061
    [Abstract] [Full Text] [Related]

  • 39. [Modification of pathologic fatty acid patterns in old age by combined clofibrinic and nicotinic acid treatment].
    Reuter W.
    Z Alternsforsch; 1983 Oct 15; 38(5):383-8. PubMed ID: 6659567
    [Abstract] [Full Text] [Related]

  • 40. Clinical and metabolic effects of pentaerythritol tetranicotinate in combination with cholesolvin or clofibrate.
    Olsson AG, Orö L, Rössner S.
    Atherosclerosis; 1974 Oct 15; 19(3):407-15. PubMed ID: 4364073
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.